期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

高凝状态与肺癌之间的关系 被引量：16

下载PDF
导出
摘要 1 背景 高凝状态（hypercoagulable state）是指多种病理因素引起的机体血管内皮细胞损伤、凝血、纤溶以及体内抗凝系统等功能失调，血液的凝固性增高，有利于血栓形成的病理状态。
作者 曹洪明 王旭 肖慧杰 徐英辉 李薇
机构地区 吉林大学白求恩第一医院肿瘤中心 吉林大学中日联谊医院结直肠肛门外科
出处 《临床和实验医学杂志》 2013年第7期553-556,共4页 Journal of Clinical and Experimental Medicine
关键词 高凝状态 肺癌 抗凝治疗
分类号 R734.2 [医药卫生—肿瘤]
  • 相关文献

参考文献20

  • 1潘磊,王勇,孙越,邓新力.经鼻无创正压通气治疗阻塞性睡眠呼吸暂停综合征血栓前状态效果评价[J].中国实用内科杂志,2006,26(7):1015-1017. 被引量：18
  • 2Abhay RS, Alok AK. Cancer - associated thrombosisan update [ J ]. Haematology, 2011,1 (2) : e39 - e45.
  • 3Spyropoulos AC, Hussein M, Lin J, et al. Rates of venous thromboembolism occurrence in medical patients among thein - sured population [J]. Thromb Haemost, 2009,102(5) :951 -957.
  • 4Khorana AA, Francis CW, Culakova E, et al. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients[J]. Cancer, 2007, 110(10) 2339-2346.
  • 5王峻,周卫华,许林,杨民,孟丽娟,樊卫飞,蒲骁麟,杨媛华.肺癌合并肺栓塞危险因素及预后的临床分析[J].中国肺癌杂志,2011,14(10):780-784. 被引量：76
  • 6Nicole H, Margarethe H, Rainer S, et al. Inducible expression of tissue factor in small - cell lung cancer: impact on morphology and matrix metalloproteinase secretion [ J]. Cancer Res Clin Oncol, 2012,138 (4) : 695 - 703.
  • 7De Cicco M. The prothrombotic state in cancer:pathogenic mechanisms [J]. Crit Rev Oncol Hematol, 2004,50(3) :187 -196.
  • 8Prandoni P, Falanga A, Piccioli A. Cancer and venous thromboembolism[ J]. Lancet Oncol, 2005,6 (6) :401 - 410.
  • 9Werle B, Kotzsch M, Lab TT, et al. Cathepsin B, plasminogen activator - inhibitor (PAI - 1 ) and plasminogen activator - receptor (uPAR) are prognostic factors for patients with non- small cell lung cancer[ J]. Anticancer Res, 2004,24(6) :4147 -4161.
  • 10Koldas M, Gummus M, Seker M, et al. Thrombin - activatable fibrinolysis inhibitor levels in patients with non - small - cell lung cancer[ J ]. Clin Lung Cancer, 2008,9(2) :112 -115.

二级参考文献18

  • 1Heit JA, Silverstein MD, Mohr DN et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med, 2000, 160(6): 809-815.
  • 2Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol, 2007, 44(2): 62-69.
  • 3Blom JW, Doggen CJ, Osanto S, et al. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA, 2005, 293(6): 715-722.
  • 4Chuang YM, Yu CJ. Clinical characteristics and outcomes of lung cancer with pulmonary embolism. Oncology, 2009, 77(2): 100-106.
  • 5Khorana AA, Francis CW, Culakova E, et al. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy.J Thromb Haemost, 2007, 5(3): 632-634.
  • 6Scarvelis D, Anderson J, Davis L, et al. Hospital mortality due to pulmonary embolism and an evaluation of the usefulness of preventative interventions. Thromb Res, 2010, 125(2): 166-170.
  • 7Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines (8th Edition). Chest, 2008, 133(6 Suppl): 381S-453S.
  • 8Zangari M, Fink LM, Elice F, et al. Thrombotic events in patients with cancer receiving antiangiogenesis agents. J Clin Oncol, 2009, 27(29): 4865 -4873.
  • 9Zhou X, Teegala S, Huen A, et al. Incidence and risk factors of venous thromboembolic events in lymphoma, Am J Med, 2010, 123(10): 935-941.
  • 10Menapace LA, Peterson DR, Berry A, et al. Symptomatic and incidental thromboembolism are both associated with mortality in pancreatic cancer. Thromb Haemost, 2011, 106(2): 371-378.

共引文献92

同被引文献151

  • 1广西柳州市工人医院检验科,韦继明,支立民,邵慧珍,王鸿利,陈后余.肺癌患者血浆D-二聚体和VWF:Ag、Fn、Fg的检测及临床意义[J].上海医学检验杂志,1995,10(1):47-47. 被引量：12
  • 2张治云,凌沛学,王凤山,张天民.低分子肝素临床应用的研究进展[J].中国生化药物杂志,2006,27(4):253-255. 被引量：34
  • 3卢瑶,许雯,边绿斐,陈少贤,王明山.肺癌患者狼疮样抗凝物质、D二聚体和活性蛋白C等测定的研究[J].实用医学杂志,2007,23(13):2017-2019. 被引量：6
  • 4刘春秋,贾彦焘.肺一丸改善肺癌患者高凝状态的研究[J].辽宁中医杂志,2007,34(8):1107-1108. 被引量：3
  • 5EdouteY,HaimN,Rinkevich D,et al.Cardiac valvlarvegetations in cancer patients:aprospectiveechocardio-graphic study of 200 patients[J].AM J Med,1997,102(3):252-258.
  • 6Khorana AA,Francis CW,Culakova E,et al.Frequency,risk factors,and trends for venous thmmboembolism among hospitalized cancer patients[J].Cancer,2007,110(10):2339-2346.
  • 7MarsteinJ,GlasmanA,Warten B,et al.Thrombosis and neoplasis[J].ThrombHeamost,1995,73(2):129.
  • 8KakkarAK,LevineMN,Kadziola Z,et al.Low molecular weight heparin,therapy with dalteparin,andsuvival in advanced cancer:thefragmin advanced malignancy outcome study(FAMOUS)[J].J Clin Oncol,2004,22(10):1944-1948.
  • 9Axel Haferkamp,Patrick J. Bastian,Hildegard Jakobi,Maria Pritsch,Jesco Pfitzenmaier,Peter Albers,Peter Hallscheidt,Stefan C. Müller,Markus Hohenfellner.Renal Cell Carcinoma With Tumor Thrombus Extension Into the Vena Cava: Prospective Long-Term Followup[J]. The Journal of Urology . 2007 (5)
  • 10Giancarlo Agnelli,Giorgio Bolis,Lorenzo Capussotti,Roberto Mario Scarpa,Francesco Tonelli,Erminio Bonizzoni,Marco Moia,Fabio Parazzini,Romina Rossi,Francesco Sonaglia,Bettina Valarani,Carlo Bianchini,Gualberto Gussoni.A Clinical Outcome-Based Prospective Study on Venous Thromboembolism After Cancer Surgery: The @RISTOS Project[J]. Annals of Surgery . 2006 (1)

引证文献16

二级引证文献67

临床和实验医学杂志
2013年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部